The results of this simulation model suggest that implementing a pharmacist-led medication reconciliation intervention at hospital discharge could be cost-saving compared with usual care.
Steven Kymes, PhD
Advertisement
Articles by Steven Kymes, PhD
Treatment of glaucoma with bimatoprost is associated with cost savings compared with treatment with latanoprost or travoprost because of greater intraocular pressure reduction.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer
3
Innovation Is Outpacing Reimbursement, Health System Execs Warn
4
FTC Reaches Settlement With CVS Caremark to Curb Insulin Rebate Practices, Cut Patient Costs
5